| Detection of AR-V7 in liquid biopsies of castrate resistant prostate cancer patients: a comparison of AR-V7 analysis in circulating tumor cells, circulating tumor RNA and exosomes M Nimir, Y Ma, SA Jeffreys, T Opperman, F Young, T Khan, P Ding, ... Cells 8 (7), 688, 2019 | 49 | 2019 |
| Single-circulating tumor cell whole genome amplification to unravel cancer heterogeneity and actionable biomarkers T Khan, TM Becker, JW Po, W Chua, Y Ma International journal of molecular sciences 23 (15), 8386, 2022 | 12 | 2022 |
| The prospect of identifying resistance mechanisms for castrate-resistant prostate cancer using circulating tumor cells: is epithelial-to-mesenchymal transition a key player? T Khan, KF Scott, TM Becker, J Lock, M Nimir, Y Ma, P de Souza Prostate cancer 2020, 2020 | 12 | 2020 |
| Prognostic and predictive value of liquid biopsy-derived androgen receptor variant 7 (AR-V7) in prostate cancer: a systematic review and meta-analysis T Khan, TM Becker, KF Scott, J Descallar, P de Souza, W Chua, Y Ma Frontiers in oncology 12, 868031, 2022 | 11 | 2022 |
| Choice of antibody is critical for specific and sensitive detection of androgen receptor splice variant-7 in circulating tumor cells T Khan, JG Lock, Y Ma, DG Harman, P de Souza, W Chua, B Balakrishnar, ... Scientific Reports 12 (1), 16159, 2022 | 2 | 2022 |
| Biomarker-Guided Drug Repurposing and Molecular Validation of Angiotensin-2 Receptor Type-1 in Brain Tumor K Konain, M Faheem, K Ullah, S Ayub, J Ahmed, Z Huma, A Javed, ... Precision Medicine Communications 3 (01), 27-42, 2023 | 1 | 2023 |
| Analysis of AR/AR-V7signalling pathways in circulating tumour cells of prostate cancer patients T Khan | | 2022 |
| Concentration of Thyroid Hormones in Blood Serum by Chemilumiscence Immunoassay T Khan, M Javed, N NasirKhattak, F Hussain, L Ali, H Nangyal | | 2015 |
